Clinical Trial Update: RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms [Phase 2]

View source ↗

Summary

This document updates the RECOVER-VITAL platform protocol and its appendix to measure Paxlovid's effects on Long COVID symptoms in a Phase 2 trial; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• PAXLOVID (Nirmatrelvir and ritonavir)

Snippet

Sponsor: Kanecia Obie Zimmerman | Conditions: Long COVID-19, Long COVID | Phase 2 | Status: COMPLETED | Results posted: 2026-03-27